Drug Profile
Darbepoetin alfa biosimilar - Dong-A ST
Alternative Names: DA-3880; Darbepoetin alpha biosimilar; Darbepoetin α biosimilar - Dong-A Pharmaceutical; GBS-011; SK-1401Latest Information Update: 17 Nov 2022
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST; Kidswell Bio; Sanwa Kagaku Kenkyusho
- Class Antianaemics; Erythropoietins; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Anaemia
Highest Development Phases
- Marketed Anaemia